CATHEDRA BITCOIN INC
CBTTF
Bitdeer Technologies
BTDR
DMG BLOCKCHAIN SOLUTIONS INC
DMGGF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Ebang International
EBON
US Stock MarketDetailed Quotes
SLN Silence Therapeutics
- 6.940
- -0.060-0.86%
Trading Dec 26 13:14 ET
327.67MMarket Cap-4.11P/E (TTM)
7.110High6.770Low98.81KVolume6.930Open7.000Pre Close683.27KTurnover0.39%Turnover RatioLossP/E (Static)47.21MShares27.72052wk High2.76P/B177.78MFloat Cap5.81052wk Low--Dividend TTM25.62MShs Float35.000Historical High--Div YieldTTM4.86%Amplitude4.545Historical Low6.915Avg Price1Lot Size
Silence Therapeutics Key Stats
EPS
According to the latest financial report of Silence Therapeutics, the latest earnings per share (TTM) for the company is -0.57. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: GBP
Quarterly
Loading...
FCF
Interested in knowing about Silence Therapeutics's free cash flow? The latest report shows it as -19.71M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: GBP
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Silence Therapeutics shows that the company's current ratio is 9.31, indicating healthy liquidity.
Currency: GBP
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Silence Therapeutics, the quick ratio is 8.61, indicating that the company can meet its short-term debt obligations.
Currency: GBP
Quarterly
Loading...
ROE
Want to learn more about the financial health of Silence Therapeutics? The latest ROE figure is -26.10%, indicating that the company has stable profitability.
Currency: GBP
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Silence Therapeutics, the total asset return on investment (ROA) is -15.09%.
Currency: GBP
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Silence Therapeutics's latest financial report to see how their gross margin is doing - currently at -142.91%.
Currency: GBP
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Silence Therapeutics, the net profit margin is -2.37K%, which is a good sign for its profitability.
Currency: GBP
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.